Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 10961868)

Published in Blood on September 01, 2000

Authors

T C Abshire1, B H Pollock, A L Billett, P Bradley, G R Buchanan

Author Affiliations

1: Emory University School of Medicine, Atlanta, GA, USA.

Articles citing this

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]. J Clin Oncol (2008) 1.83

Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int J Nanomedicine (2006) 1.28

Therapeutic strategies impacting cancer cell glutamine metabolism. Future Med Chem (2013) 1.12

A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase. J Clin Invest (2009) 1.05

A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. Leukemia (2010) 1.03

Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia. Clin Pharmacol Ther (2009) 1.01

Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine. Cancer Res (2013) 0.99

Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn? Pediatr Blood Cancer (2011) 0.94

Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). J Pediatr Hematol Oncol (2011) 0.88

Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia. Clin Med Insights Oncol (2014) 0.87

Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9). J Pediatr Hematol Oncol (2013) 0.83

First-line treatment of acute lymphoblastic leukemia with pegasparaginase. Biologics (2009) 0.83

Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764). J Pediatr Hematol Oncol (2013) 0.77

Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice. J Biol Chem (2013) 0.76

Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program. Pediatr Blood Cancer (2014) 0.76

L-asparaginase in the treatment of patients with acute lymphoblastic leukemia. J Pharmacol Pharmacother (2016) 0.75

A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1. J Pediatr Hematol Oncol (2016) 0.75

Articles by these authors

PRINTS and its automatic supplement, prePRINTS. Nucleic Acids Res (2003) 10.01

Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol (1993) 3.41

Plasma homocysteine levels and folate status in children with sickle cell anemia. J Pediatr Hematol Oncol (1999) 3.27

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med (1994) 3.26

High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med (1994) 3.10

A complex of nuclear pore proteins required for pore function. J Cell Biol (1991) 2.87

A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol (2001) 2.67

Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost (2015) 2.46

Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med (1995) 2.38

Towards automated cellular image segmentation for RNAi genome-wide screening. Med Image Comput Comput Assist Interv (2005) 2.19

National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health (1997) 2.17

Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (2001) 2.10

The acute chest syndrome of sickle cell disease. J Pediatr (1999) 2.04

Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr (1996) 1.84

Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr (1998) 1.77

Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med (1994) 1.67

Comparison of laparoscopic and open splenectomy in children with hematologic disorders. J Pediatr (1997) 1.67

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr (1996) 1.66

Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J (1992) 1.61

Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes. J Pediatr (1990) 1.59

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood (1998) 1.57

Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet (2002) 1.56

Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer (1996) 1.56

Induction by alkylating agents of sister chromatid exchanges and chromatid breaks in Fanconi's anemia. Proc Natl Acad Sci U S A (1975) 1.55

Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol (1997) 1.55

The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J (1995) 1.52

Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1994) 1.51

Catheter-related thrombosis in children with cancer. J Pediatr (2001) 1.51

Seasonal variations in the diagnosis of childhood cancer in the United States. Br J Cancer (1999) 1.50

Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. J Clin Oncol (1996) 1.50

Residential pesticide exposure and neuroblastoma. Epidemiology (2001) 1.47

Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence. Rheumatology (Oxford) (2008) 1.46

Malabsorption and defective utilization of iron in three siblings. J Pediatr (1981) 1.44

Outpatient management of febrile illness in infants and young children with sickle cell anemia. J Pediatr (1990) 1.41

Implantable venous access devices in children with hemophilia: a report of low infection rates. J Pediatr (1998) 1.40

SAPPHIRE: scenarios, architecture, and process. Comput Methods Programs Biomed (1994) 1.39

Endoscopic retrograde cholangiopancreatography in the investigation and management of patients after acute pancreatitis. Br J Surg (1982) 1.38

The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood (1990) 1.36

Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol (2001) 1.35

Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society. Br J Ophthalmol (2002) 1.35

Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol (1983) 1.32

Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood (1993) 1.30

Use of alternative therapies for children with cancer. Pediatrics (1997) 1.28

Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. J Pediatr (1995) 1.27

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry (2001) 1.25

Acute infarction of long bones in children with sickle cell anemia. J Pediatr (1982) 1.23

Severe hemolytic anemia in black children with glucose-6-phosphate dehydrogenase deficiency. Pediatrics (1982) 1.23

Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol (2000) 1.21

Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer (2000) 1.21

Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer (2006) 1.21

Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia. J Pediatr (1995) 1.21

Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol (1986) 1.20

Programs for adult survivors of childhood cancer. J Clin Oncol (1998) 1.19

Performance of residents in anesthesiology as related to measures of personality and interests. Psychol Rep (1991) 1.16

Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia. Am J Dis Child (1986) 1.15

Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia (2004) 1.14

Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (1996) 1.14

Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim/sulfamethoxazole. J Clin Oncol (1994) 1.13

Genetic mapping of the BRCA1 region on chromosome 17q21. Am J Hum Genet (1994) 1.13

Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer (2001) 1.13

Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma (1997) 1.12

Parental occupational exposures to chemicals and incidence of neuroblastoma in offspring. Am J Epidemiol (2001) 1.11

Functional asplenia in hemoglobin SC disease. Blood (1995) 1.11

Quality of life research in pediatric oncology. Research methods and barriers. Cancer (1996) 1.08

Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood (2000) 1.07

Re: Planning the consultant workforce in oral & maxillofacial surgery. Br J Oral Maxillofac Surg (1999) 1.07

Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro. Leukemia (2000) 1.07

The temporalis muscle flap in oral reconstruction. A cadaveric, animal and clinical study. J Maxillofac Surg (1981) 1.06

Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia. Leukemia (2000) 1.06

Neonatal coagulation: normal physiology and pathophysiology. Clin Haematol (1978) 1.05

Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial. Am J Pediatr Hematol Oncol (1984) 1.05

Polymorphic SSR (simple-sequence-repeat) markers for chromosome 20. Genomics (1993) 1.04

Changes in the structure of synapses associated with learning. J Neurosci (1985) 1.04

Diamond-Blackfan syndrome in adult patients. Am J Med (1985) 1.04

The nontreatment of childhood idiopathic thrombocytopenic purpura. Eur J Pediatr (1987) 1.04

Pediatric residents' continuity clinics: how are we really doing? Pediatrics (1995) 1.03

Plasma and erythrocyte lipids in sickle cell anaemia. Clin Lab Haematol (1983) 1.03

Parental occupational exposures to electromagnetic fields and radiation and the incidence of neuroblastoma in offspring. Epidemiology (2001) 1.02

Intravenous narcotic therapy for children with severe sickle cell pain crisis. Am J Dis Child (1986) 1.01

Survey of total mercury in total diet food composites and an estimation of the dietary intake of mercury by adults and children from two Canadian cities, 1998-2000. Food Addit Contam (2003) 1.01

Leukocyte counts in children with sickle cell disease. Comparative values in the steady state, vaso-occlusive crisis, and bacterial infection. Am J Dis Child (1978) 1.00

Acute chest syndrome in children with sickle cell disease. A retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol Oncol (1986) 1.00

High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone. J Pediatr (1995) 0.99

Effects of resistance training on insulin-like growth factor-I and IGF binding proteins. Med Sci Sports Exerc (2001) 0.99

Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia. Cancer (1997) 0.99

Leiomyosarcoma of the larynx. Otolaryngol Head Neck Surg (1999) 0.99

Neuroblastoma and parental occupation. Cancer Causes Control (1999) 0.99

Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst (1992) 0.99

Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia. Br J Haematol (2007) 0.98

Mechanisms of immunosuppression: effect of cyclophosphamide on responses to influenza immunization. J Lab Clin Med (1974) 0.98

Oral penicillin prophylaxis in children with imparied splenic function: a study of compliance. Pediatrics (1982) 0.98

Intracranial hemorrhage in newborn and young infants with hemophilia. J Pediatr (1988) 0.97

Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol (1992) 0.97

Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions. Transfusion (2001) 0.96

Catheter-related deep venous thrombosis in children with hemophilia. Blood (2001) 0.96

Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr (1993) 0.96

Care of the critically ill child: the bleeding neonate. Pediatrics (1976) 0.96

The growth of the dendritic trees of Purkinje cells in the cerebellum of the rat. Brain Res (1976) 0.96

Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol (2000) 0.95